Today: 19 January 2026
Subscribe
Browse Category

Mergers & Acquisitions News 19 November 2025 - 21 November 2025

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Pfizer has closed its up to $10 billion acquisition of Metsera (MTSR) and raised $6 billion in bonds to help fund the deal. Here’s what today’s developments mean for former Metsera shareholders, Pfizer investors and the future of the obesity drug market. What Happened Today: Pfizer Locks In $6 Billion Bond Financing The main fresh headline for 21 November 2025…
21 November 2025
····
Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri Corporation (NYSE: NVRI) has kicked off one of the most consequential restructurings in its 170‑year history, agreeing to sell its Clean Earth hazardous‑waste business to France’s Veolia Environnement for $3.04 billion in cash and unveiling plans to spin off its remaining Harsco Environmental and Rail units into a new standalone public company dubbed “New Enviri.” Enviri The deal, announced…
21 November 2025
···
Ondas Holdings (ONDS) Jumps on $35M PDW Combat Robotics Deal as Sentrycs Acquisition Reshapes Drone-Defense Strategy – 21 November 2025

Ondas Holdings (ONDS) Jumps on $35M PDW Combat Robotics Deal as Sentrycs Acquisition Reshapes Drone-Defense Strategy – 21 November 2025

Today’s Headline: Ondas Pours $35M into PDW to Scale Combat Robotics The main catalyst for Ondas Holdings Inc. (ONDS) in the news cycle on 21 November 2025 is the market’s reaction to its $35 million strategic investment in Performance Drone Works (PDW), a fast‑growing U.S. defense‑technology company focused on combat robotics. Ondas Holdings Inc. According to Ondas’ 20 November press…
21 November 2025
····
Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (NYSE: ABT) shook the healthcare and medtech markets today, November 20, 2025, by announcing a definitive agreement to acquire cancer diagnostics specialist Exact Sciences Corporation (NASDAQ: EXAS) in an all‑cash transaction valuing the target at about $21 billion in equity and roughly $23 billion including debt. Reuters The move marks Abbott’s largest acquisition in nearly a decade and…
20 November 2025
····
Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott has agreed to acquire cancer diagnostics specialist Exact Sciences in a cash deal valued at about $21 billion in equity, or roughly $23 billion including debt, in one of the biggest healthcare transactions of 2025 and Abbott’s largest deal in nearly a decade. Abbott MediaRoom The transaction gives Abbott an immediate leadership position in fast‑growing cancer screening and precision…
20 November 2025
····
Spectris PLC Share Price Today (20 November 2025): LON:SXS Holds Just Below £41.75 KKR Takeover Price

Spectris PLC Share Price Today (20 November 2025): LON:SXS Holds Just Below £41.75 KKR Takeover Price

Spectris plc (LON:SXS), the precision measurement specialist and FTSE 250 constituent, continues to trade tightly around its pending takeover price as the market absorbs a fresh wave of disclosure notices and takeover‑related updates. Spectris share price today: 20 November 2025 snapshot As of Thursday 20 November 2025, Spectris PLC’s share price is trading at 4,108.0p (approximately £41.08) on the London Stock Exchange. That…
20 November 2025
····
Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

PANW Stock Today (Nov 19, 2025): Palo Alto Networks beats Q1, announces $3.35B Chronosphere deal; shares swing after hours

November 19, 2025 — Palo Alto Networks (NASDAQ: PANW) packed multiple headlines into one day: fiscal Q1 2026 results that grew double‑digits, a definitive agreement to buy observability platform Chronosphere for $3.35 billion, a board refresh, and a new quantum‑safe collaboration with IBM.  PR Newswire PANW stock price snapshot (after hours) Following the release, PANW shares whipsawed in late trading, changing hands around $199.90 as of 21:30…
19 November 2025
····
Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Updated: November 19, 2025 SANTA CLARA, Calif. — Palo Alto Networks announced today that it has entered into a definitive agreement to acquire Chronosphere, a fast‑growing cloud‑native observability platform, in a deal valued at $3.35 billion to be paid in cash and replacement equity awards. The companies said the transaction is expected to close in the second half of Palo Alto Networks’ fiscal 2026,…
19 November 2025
···
EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

Exact Sciences Corporation (NASDAQ: EXAS) is surging today after reports that healthcare giant Abbott Laboratories is in advanced talks to acquire the cancer diagnostics specialist. Shares of EXAS spiked sharply intraday, briefly approaching new 52‑week highs as traders rushed into the name on renewed takeover speculation.  Reuters Key points EXAS stock today: price, move, and trading activity According to Exact…
19 November 2025
····
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire cancer diagnostics specialist Exact Sciences, in what could be the healthcare giant’s largest deal in nearly a decade and a major shake-up for the global cancer testing market. Bloomberg Abbott in Talks for Biggest Deal in Nearly a Decade On Wednesday, November 19, 2025, multiple outlets reported that Abbott Laboratories is close…
19 November 2025
····
Semrush Stock Soars 75% Today as Adobe Announces $1.9 Billion Cash Takeover – What SEMR Investors Need to Know (19 November 2025)

Semrush Stock Soars 75% Today as Adobe Announces $1.9 Billion Cash Takeover – What SEMR Investors Need to Know (19 November 2025)

Semrush Holdings, Inc. (NYSE: SEMR) is one of the hottest stocks in the market today after Adobe unveiled a definitive agreement to acquire the AI‑driven marketing and SEO platform in a $1.9 billion all‑cash deal. Adobe Newsroom As of the latest trade this afternoon on 19 November 2025, Semrush shares are changing hands around $11.8, up roughly 74% on the day, after trading between about $6.82 and $11.87 in…
19 November 2025
····
Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings Inc. (NASDAQ: ONDS) remains one of the most talked‑about small‑cap defense and drone stocks this month. After a blistering rally driven by record third‑quarter results and a flurry of acquisitions, the stock is consolidating on Wednesday, November 19, 2025, as fresh research notes highlight both its explosive growth and its continuing risks. By mid‑afternoon, ONDS shares were trading…
19 November 2025
····
1 … 19 20 21 22 23 … 34

Stock Market Today

  • Nvidia Eyes $500 Target by 2026 on AI Market Dominance and Data Center Growth
    January 18, 2026, 9:25 PM EST. Nvidia's stock is on a strong bullish trajectory, with 44 of 48 analysts rating it a "Strong Buy" and averaging a $264.97 price target-a potential 43% upside from current levels. The chipmaker dominates 80-95% of the AI GPU market, thanks to its CUDA software ecosystem, used by over 4 million developers. Its data center revenue, expected to reach $51.2 billion by fiscal 2026, now surpasses gaming as the key growth driver. Analysts highlight a massive $500 billion demand in Blackwell/Rubin chip cycles through 2026 and a re-entry into China, possibly adding $54 billion in revenue despite regulatory challenges. Yet, risks remain from AI bubble fears, geopolitical tensions, and cautious market sentiment. The $3-4 trillion AI infrastructure market by 2030 offers long-term upside but demands investor caution amid uncertainties.
Go toTop